background
rapid
test
signific
impact
influenza
diagnosi
accur
test
need
hospit
patient
test
neg
rapid
method
object
sought
determin
increas
yield
obtain
influenza
rtpcr
hospit
patient
compar
two
rapid
method
studi
design
binax
cytospinenhanc
direct
immunofluoroesc
dfa
influenza
b
multiplex
taqman
rtpcr
perform
clinic
sampl
result
binax
detect
cytospindfa
detect
taqman
rtpcr
detect
influenzaposit
sampl
differ
sensit
signific
rtpcr
binax
p
rtpcr
cytospindfa
p
two
sampl
test
posit
influenza
b
three
method
test
fals
posit
influenza
binax
eight
true
posit
sampl
becom
reactiv
binax
min
thu
count
neg
conclus
accuraci
realtim
rtpcr
greatli
improv
diagnosi
influenza
hospit
use
simpl
rapid
flu
test
may
modest
impact
hospit
expertis
cytospindfa
studi
need
determin
effect
influenza
rtpcr
patient
manag
cost
hospit
patient
impact
influenza
morbid
mortal
young
children
well
elderli
adult
increasingli
recogn
cdc
earli
diagnosi
impact
therapi
reduc
unnecessari
test
treatment
barenfang
et
al
bonner
et
al
past
laboratori
diagnosi
influenza
larg
confin
cultur
special
laboratori
recent
year
rapid
simpl
influenza
test
becom
wide
implement
gener
laboratori
point
care
hurt
et
al
introduct
realtim
molecular
method
commerci
kit
polymeras
chain
reaction
pcr
access
hospit
laboratori
becom
option
replac
cultur
boivin
et
al
hospit
cytospinenhanc
direct
immunofluoresc
dfa
perform
respiratori
sampl
virolog
open
rapid
influenza
test
binax
use
core
laboratori
virolog
close
landri
ferguson
landri
et
al
cultur
reserv
hospit
patient
due
shorter
assay
time
greater
sensit
pcr
convent
cultur
multiplex
realtim
rtpcr
procedur
influenza
b
valid
clinic
use
laboratori
ward
et
al
part
valid
process
prospect
studi
perform
subset
clinic
sampl
determin
increas
yield
obtain
pcr
hospit
patient
total
nasopharyng
swab
patient
collect
viral
transport
medium
remel
lenexa
ks
submit
clinic
virolog
laboratori
januari
april
respiratori
viru
dfa
util
patient
rang
age
month
year
year
year
age
specimen
transport
laboratori
within
h
collect
enter
studi
adequ
sampl
avail
test
three
method
sinc
dfaneg
sampl
could
test
dfaneg
inadequ
sampl
less
respiratori
epitheli
cell
inpati
includ
sampl
test
receipt
dfa
binax
b
two
sampl
test
posit
influenza
b
three
method
also
test
fals
posit
influenza
eight
true
posit
sampl
two
influenza
six
influenza
b
reactiv
min
incub
call
neg
aliquot
frozen
lysi
buffer
c
batch
test
within
week
rtpcr
studi
period
reflex
viral
cultur
order
physician
anoth
dfaneg
nonstudi
sampl
hospit
patient
sampl
inocul
primari
rhesu
monkey
kidney
rhmk
cell
roller
tube
incub
c
examin
cpe
hemadsorpt
day
influenza
detect
rate
cultur
sampl
compar
studi
sampl
test
pcr
cytospin
enhanc
dfa
use
simulfluor
respiratori
screen
reagent
chemicon
temecula
ca
binax
binax
inc
portland
perform
previous
describ
landri
ferguson
binax
result
read
min
accord
manufactur
instruct
nucleic
acid
l
sampl
extract
use
nuclisen
easymag
biomerieux
durham
nc
multiplex
onestep
influenza
b
taqman
rtpcr
assay
perform
use
previous
publish
primer
probe
ward
et
al
univers
master
mix
ung
multiscrib
appli
biosystem
nm
primer
nm
probe
l
nucleic
acid
extract
reaction
amplif
protocol
consist
c
min
one
cycl
min
c
follow
cycl
c
min
c
cycl
threshold
consid
true
posit
dfaneg
sampl
c
reextract
test
duplic
replic
posit
sampl
call
posit
rtpcr
sensit
influenza
b
rtpcr
consid
refer
standard
subset
sampl
monitor
inhibitor
none
found
result
binax
cytospindfa
rtpcr
shown
tabl
one
hundr
thirtytwo
sampl
posit
rtpcr
cytospindfa
binax
differ
sensit
binax
dfa
binax
rtpcr
signific
p
differ
dfa
rtpcr
p
mcnemar
test
result
detect
influenza
b
similar
impact
age
sensit
binax
dfa
minim
tabl
two
sampl
posit
influenza
b
three
method
test
fals
posit
influenza
binax
one
fals
reactiv
influenza
stronger
true
reactiv
influenza
b
eight
true
posit
sampl
two
influenza
six
influenza
b
becam
reactiv
binax
min
incub
accord
kit
instruct
result
must
read
min
avoid
erron
result
thu
consid
neg
sixtytwo
binax
neg
sampl
rtpcr
posit
specif
cytospinenhanc
respiratori
screen
dfa
high
dfa
posit
confirm
pcr
one
sampl
fail
confirm
pcr
one
dfa
posit
cell
could
true
posit
purpos
studi
deem
fals
posit
c
valu
sampl
posit
dfa
binax
rang
median
c
valu
sampl
posit
dfa
neg
binax
rang
median
eight
sampl
delay
reactiv
binax
thu
classifi
neg
c
valu
relat
c
valu
dfa
binax
result
given
fig
c
result
influenza
b
significantli
differ
combin
five
dfaneg
sampl
found
influenza
posit
rtpcr
tabl
c
valu
rang
median
four
five
adult
influenzalik
ill
day
one
child
underli
diseas
prior
posit
sampl
separ
studi
shown
cultureposit
sampl
gener
c
valu
data
shown
thu
one
five
sampl
would
expect
cultur
posit
sinc
studi
perform
part
test
valid
prior
clinic
use
sampl
batch
test
pcr
current
influenza
pcr
assay
perform
day
monday
friday
accord
day
time
receipt
lab
result
sampl
would
report
h
median
h
compar
influenza
b
rtpcr
sensit
specif
posit
neg
predict
valu
binax
cytospindfa
separ
dfaneg
sampl
cultur
clinic
purpos
three
influenza
posit
detect
eight
adenoviru
rhinoviru
parainfluenza
type
herp
simplex
type
cytomegaloviru
also
isol
rapid
flu
test
simpl
fast
requir
equip
perform
point
care
situat
test
use
hospit
patient
sensit
specif
diagnosi
may
warrant
dfa
rapid
cell
cultur
convent
cell
cultur
pcr
option
studi
assess
potenti
impact
influenza
b
rtpcr
hospit
patient
select
dfa
neg
inadequ
sampl
hospit
patient
rather
random
sampl
could
introduc
bia
howev
sought
evalu
util
pcr
would
employ
hospit
pcr
greatli
enhanc
accuraci
influenza
detect
compar
rapid
flu
test
detect
addit
posit
beyond
detect
binax
binax
also
two
fals
posit
influenza
result
note
transport
media
use
laboratori
sinc
allow
multipl
test
includ
rapid
flu
dfa
cultur
pcr
perform
one
sampl
howev
possibl
binax
would
perform
better
differ
low
volum
collect
fluid
concentr
sampl
convent
cultur
standard
clinic
test
dfaneg
sampl
facil
studi
period
reflex
cultur
perform
dfaneg
sampl
three
influenza
posit
detect
contrast
pcr
detect
five
addit
influenza
posit
sampl
dfaneg
dfa
inadequ
thu
pcr
provid
higher
yield
cultur
expect
analyt
sensit
pcr
assay
ultim
impact
influenza
diagnosi
manag
hospit
patient
depend
sensit
also
time
result
antivir
treatment
given
within
h
symptom
onset
time
patient
arriv
hospit
shown
tabl
often
day
alreadi
pass
infect
control
practic
implement
best
result
prior
bed
assign
likewis
avert
unnecessari
use
antibiot
diagnost
test
result
close
time
admiss
possibl
sensit
rapid
test
option
dfa
result
avail
fastest
name
within
h
virolog
open
within
h
sampl
submit
virolog
close
howev
dfa
accuraci
vari
laboratori
cytospin
prepar
slide
rare
employ
newer
rmix
cell
cultur
within
capabl
laboratori
highli
sensit
influenza
result
report
day
barenfang
et
al
dunn
et
al
institut
influenza
b
pcr
perform
day
day
week
thu
time
result
h
weekday
h
weekend
five
sampl
detect
pcr
result
would
report
h
beyond
h
window
recommend
antivir
therapi
util
pcr
would
greatli
enhanc
multiplex
includ
multipl
virus
retain
sensit
greater
cultur
virus
detect
dfa
coronavirus
rhinovirus
includ
perform
least
day
commerci
avail
kit
use
convent
rtpcr
detect
multipl
respiratori
viru
target
lee
et
al
li
et
al
mahoni
et
al
nolt
et
al
howev
frequenc
assay
could
perform
routin
hospit
laboratori
remain
uncertain
import
note
multiplex
pcr
assay
may
sensit
influenza
rsv
two
import
viral
respiratori
pathogen
lee
et
al
influenza
b
mahoni
et
al
therefor
critic
laboratori
compar
newer
method
laboratori
valid
improv
sensit
current
method
date
cost
benefit
rapid
influenza
test
children
bonner
et
al
respiratori
viru
cytospin
dfa
adult
children
barenfang
et
al
bonner
et
al
shown
clinic
cost
benefit
whether
respiratori
viru
pcr
also
favor
costbenefit
profil
known
requir
prospect
control
studi
stratifi
age
patient
sever
diseas
presenc
comorbid
condit
studi
rtpcr
influenza
b
detect
mani
addit
posit
detect
binax
small
number
posit
detect
cytospindfa
accuraci
realtim
rtpcr
signific
benefit
hospit
use
simpl
rapid
influenza
test
may
modest
impact
hospit
expertis
cytospindfa
studi
need
assess
impact
influenza
pcr
includ
highli
multiplex
assay
patient
outcom
cost
hospit
set
